🔗 Permalink

Inventor profile of:

Lars Linderoth

City:

Hilleroed

Country:

Denmark

Published Applications:

Last publication date:

2026-05-07

Top Assignees for applications by Lars Linderoth

The entities that hold a legal rights for patent applications filed by inventor Linderoth Lars:

Novo Nordisk A/S 6 Bagsvaerd, Denmark

Recent patent applications by Linderoth Lars

Lars Linderoth from Hilleroed, DK has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-07

US20260125445A1

Chemistry; metallurgy

GLP-1 DERIVATIVES AND USES THEREOF

#2 | 2023-08-31

US20230272029A1

Chemistry; metallurgy

CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY

#3 | 2022-06-09

US20220177538A1

Chemistry; metallurgy

CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY

#4 | 2022-04-28

US20220125940A1

Human necessities

Co-agonists at GLP-1 and GIP receptors suitable for oral delivery

#5 | 2020-12-31

US20200407409A1

Chemistry; metallurgy

EGF(A) ANALOGUES WITH FATTY ACID SUBSTITUENTS

#6 | 2020-03-12

US20200079834A1

Chemistry; metallurgy

Double-acylated GLP-1 derivatives

#7 | 2019-02-07

US20190038721A1

Human necessities

GLP-1 derivatives and uses thereof

#8 | 2019-01-17

US20190016768A1

Chemistry; metallurgy

EGF(A) analogues with fatty acid substituents

#9 | 2018-09-06

US20180251512A1

Chemistry; metallurgy

Double-acylated GLP-1 derivatives

#10 | 2018-01-18

US20180016319A1

Chemistry; metallurgy

Acylated Glucagon Analogues

#11 | 2017-03-02

US20170058014A1

Chemistry; metallurgy

Double-acylated GLP-1 derivatives

InventorID:

1810061 ⎘